In this July 1, 2021 interview, Merck leaders discuss how the company’s approach to promoting patient diversity includes confronting root cause challenges in trial design and elsewhere that have been obstacles to attaining wider diversity in the patient population.
In this June 25, 2021 discussion, Burgess and Pastuszak describe how decentralized clinical trials can improve trial diversity, speed study start-up, and perhaps stem the “one and done” phenomenon for some Principal Investigators.
“The recruitment phase of a clinical trial is probably the most important differentiator” among Contract Research Organizations (CROs) says Dr. Bhan in this April 28, 2021 discussion. He describes how technology can help narrow and process data to make it easier to recruit and retain the right patients for the right trial.
In this April 14, 2021 segment, cyclist Fisher discusses how he and co-rider Sergio Armani hope to raise more than $15,000 to help advance racial diversity in the clinical trial workforce with their bike ride from Pennsylvania to ACRP’s headquarters in Alexandria, VA in June.